Ward Medication Management Ward Medication Management Ward Medication Management Ward Medication Management
  • Home
  • About Us
  • Services
  • Partners
  • Careers
  • News
  • Knowledge Hub
  • Contact Us
  • Sign In
Ward Medication Management Ward Medication Management
  • Home
  • About Us
  • Services
  • Partners
  • Careers
  • News
  • Knowledge Hub
  • Contact Us
  • Sign In
Feb 14

Ward Clinical Pearl: 14 February 2017 – Generic medicines (part 2)

  • February 14, 2017
  • Joanna Foy
  • No Comments
  • Clinical Pearls

Each week we will aim to bring out a concise email that provides 4-5 key pieces of information addressing a specific issue in clinical therapeutics.

 

This week: Generic medicines (part 2)

At one stage primarily used in hospitals as a result to tendering in procurement processes, generic medication products are now widespread in the aged care sector, and indeed in the general community. Consumer choice may be a driving factor, as people strive to achieve best value for money when purchasing pharmaceuticals.

 

  • As different generic brands of medication may look and be packaged in very different ways, consumers and their families may become confused by apparent changes that are not communicated clearly. For example, a person living independently in the community may be admitted to a hospital where a different brand of a medication is in use, and discharged to an aged care facility where yet another brand of the same drug is in use. Unless there is clear communication, concerns may arise.
  • A community pharmacy supplying medications supplying medications for a nursing home may negotiate to purchase a particular brand of generic medicine for a competitive price – the savings are passed on to consumers. Before proceeding down this path, the pharmacy will take appropriate steps to be sure that the brand selected is of a high standard of safety and quality. The packing equipment used in the pharmacy may require specific adjustment to accommodate the characteristics of a specific brand, meaning that it is undesirable to switch between brands frequently.
  • In some cases generic brand alternatives may not be available, meaning that the originator brand of the medicine is the only brand available for use in Australia (other brands may exist overseas, but may not be available on the Australian market).

 

Please consider these issues when preparing or interpreting RMMR reports or education sessions. Contributions of content or suggested topics are welcome and should be sent directly to chris@wardmm.com.au.

  • Facebook
  • Twitter
  • Tumblr
  • Pinterest
  • Google+
  • LinkedIn
  • E-Mail

About The Author

Leave a reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Ward Clinical Pearl: 17 April 2018 – Methotrexate SC Injection
  • Ward Clinical Pearl: 10 April 2018 – Direct/Newer Anticoagulants Part 2
  • Ward Clinical Pearl: 3 April 2018 – Direct/Newer Anticoagulants Part 1
  • Ward MM Newsletter March 2018
  • Ward Clinical Pearl: 27 March 2018 – Updating Medicine Ingredients Names Part 2

Archives

  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015

Categories

  • Clinical Pearls
  • Company News
  • Newsletters

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

© Ward Medication Management 2017 All Rights Reserved | Privacy Policy | Ethics Statement